Hiroaki Takemoto

1.6k total citations
39 papers, 1.3k citations indexed

About

Hiroaki Takemoto is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Hiroaki Takemoto has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 6 papers in Complementary and alternative medicine. Recurrent topics in Hiroaki Takemoto's work include Cardiovascular Health and Disease Prevention (6 papers), Tea Polyphenols and Effects (5 papers) and Pharmacology and Obesity Treatment (4 papers). Hiroaki Takemoto is often cited by papers focused on Cardiovascular Health and Disease Prevention (6 papers), Tea Polyphenols and Effects (5 papers) and Pharmacology and Obesity Treatment (4 papers). Hiroaki Takemoto collaborates with scholars based in Japan and United States. Hiroaki Takemoto's co-authors include Masumi Takemoto, Michiho Ito, Junko Soga, Shuji Nakamura, Daisuke Jitsuiki, Kazuaki Chayama, Toru Yagura, Takashi Umemura, Kenji Nishioka and Chikara Goto and has published in prestigious journals such as Journal of the American College of Cardiology, Neuroscience and CHEST Journal.

In The Last Decade

Hiroaki Takemoto

39 papers receiving 1.2k citations

Peers

Hiroaki Takemoto
Hatem M. Abuohashish Saudi Arabia
Michael Éverton Andrades Brazil
Eser Yıldırım Sözmen Türkiye
Suthiluk Patumraj Thailand
Jinghua Peng China
Sara Nunes Portugal
Suzanne A. Nasser Lebanon
Mohammed M. Ahmed Saudi Arabia
Hatem M. Abuohashish Saudi Arabia
Hiroaki Takemoto
Citations per year, relative to Hiroaki Takemoto Hiroaki Takemoto (= 1×) peers Hatem M. Abuohashish

Countries citing papers authored by Hiroaki Takemoto

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Takemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Takemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Takemoto more than expected).

Fields of papers citing papers by Hiroaki Takemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Takemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Takemoto. The network helps show where Hiroaki Takemoto may publish in the future.

Co-authorship network of co-authors of Hiroaki Takemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Takemoto. A scholar is included among the top collaborators of Hiroaki Takemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Takemoto. Hiroaki Takemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shirahata, Tatsuya, Hiroshi Ishikawa, Hiroaki Takemoto, et al.. (2021). Metabolic fingerprinting for discrimination of DNA-authenticated Atractylodes plants using 1H NMR spectroscopy. Journal of Natural Medicines. 75(3). 475–488. 11 indexed citations
2.
Ito, Naoki, et al.. (2020). Neuroinflammaging underlies emotional disturbances and circadian rhythm disruption in young male senescence-accelerated mouse prone 8 mice. Experimental Gerontology. 142. 111109–111109. 9 indexed citations
3.
Ito, Naoki, Kazunori Sasaki, Hiroaki Takemoto, et al.. (2020). Emotional Impairments and Neuroinflammation are Induced in Male Mice Invulnerable to Repeated Social Defeat Stress. Neuroscience. 443. 148–163. 10 indexed citations
4.
Sato, Naoko, Wei Li, Hiroaki Takemoto, et al.. (2018). Comprehensive evaluation of antioxidant effects of Japanese Kampo medicines led to identification of Tsudosan formulation as a potent antioxidant agent. Journal of Natural Medicines. 73(1). 163–172. 5 indexed citations
5.
Takemoto, Masumi & Hiroaki Takemoto. (2018). Synthesis of Theaflavins and Their Functions. Molecules. 23(4). 918–918. 98 indexed citations
6.
Oshima, Naohiro, Takuro Maruyama, Nahoko Uchiyama, et al.. (2017). Two flavone C-glycosides as quality control markers for the manufacturing process of ephedrine alkaloids-free Ephedra Herb extract (EFE) as a crude drug preparation. Journal of Natural Medicines. 72(1). 73–79. 13 indexed citations
7.
8.
Michimae, Hirofumi, Hiroaki Takemoto, Aya Sasaki, et al.. (2016). Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity. Molecular Pharmacology. 90(3). 265–274. 10 indexed citations
9.
Takemoto, Hiroaki, Michiho Ito, Yoshihisa Asada, & Yoshinori Kobayashi. (2015). Inhalation Administration of the Sesquiterpenoid Aristolen-1(10)-en-9-ol from Nardostachys chinensis Has a Sedative Effect via the GABAergic System. Planta Medica. 81(5). 343–347. 22 indexed citations
10.
Kobayashi, Yoshinori, et al.. (2014). Effects of L-citrulline diet on stress-induced cold hypersensitivity in mice. Pharmacognosy Research. 6(4). 297–297. 7 indexed citations
11.
Huang, Xuedan, Eri Maeda, Yoshihisa Asada, et al.. (2014). Cytotoxic activity of two natural sesquiterpene lactones, isobutyroylplenolin and arnicolide D, on human colon cancer cell line HT-29. Natural Product Research. 28(12). 914–916. 25 indexed citations
12.
Takemoto, Hiroaki, Toru Yagura, & Michiho Ito. (2009). Evaluation of volatile components from spikenard: valerena-4,7(11)-diene is a highly active sedative compound. Journal of Natural Medicines. 63(4). 380–385. 37 indexed citations
13.
Umemura, Takashi, Junko Soga, Hiroaki Takemoto, et al.. (2008). Aging and Hypertension Are Independent Risk Factors for Reduced Number of Circulating Endothelial Progenitor Cells. American Journal of Hypertension. 21(11). 1203–1209. 76 indexed citations
14.
Takemoto, Hiroaki, Michiho Ito, Tomohiro Shiraki, Toru Yagura, & Gisho Honda. (2007). Sedative effects of vapor inhalation of agarwood oil and spikenard extract and identification of their active components. Journal of Natural Medicines. 62(1). 41–46. 135 indexed citations
15.
Habara, Seiji, Keigo Dote, Masashi Kato, et al.. (2007). Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. European Heart Journal. 28(18). 2217–2222. 89 indexed citations
16.
Umemura, Takashi, Keiko Ueda, Kenji Nishioka, et al.. (2006). Effects of Acute Administration of Caffeine on Vascular Function. The American Journal of Cardiology. 98(11). 1538–1541. 145 indexed citations
17.
Kato, Masaya, Keigo Dote, Shota Sasaki, et al.. (2005). Determination of the Optimal Atrioventricular Interval in Sick Sinus Syndrome During DDD Pacing. Pacing and Clinical Electrophysiology. 28(9). 892–897. 2 indexed citations
18.
Kato, Masaya, Keigo Dote, Shota Sasaki, et al.. (2004). Intracoronary Verapamil Rapidly Terminates Reperfusion Tachyarrhythmias in Acute Myocardial Infarction. CHEST Journal. 126(3). 702–708. 20 indexed citations
19.
Takemoto, Hiroaki, et al.. (2003). Calcium Antagonists and/or Nitrates Do Not Prevent Reinfarction Due to Vulnerable Plaque Rupture during the First Year after Myocardial Infarction. Japanese Circulation Journal-english Edition. 67. 203–204. 1 indexed citations
20.
Kato, Masaya, et al.. (2003). Clinical implications of carotid artery remodeling in acute coronary syndrome. Journal of the American College of Cardiology. 42(6). 1026–1032. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hatem M. Abuohashish Breakdown of academic impact, for papers by Michael Éverton Andrades Breakdown of academic impact, for papers by Eser Yıldırım Sözmen Breakdown of academic impact, for papers by Suthiluk Patumraj Breakdown of academic impact, for papers by Jinghua Peng Breakdown of academic impact, for papers by Sara Nunes Breakdown of academic impact, for papers by Suzanne A. Nasser Breakdown of academic impact, for papers by Mohammed M. Ahmed
Rankless by CCL
2026